Naomi Y Ko, MD, MPH
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MD, Johns Hopkins University School of Medicine
MPH, Johns Hopkins University School of Public Health
AM, Harvard University

Pronouns: she/her/hers

Breast Cancer
Cancer Disparities
Health Equity

Dr. Ko is an Associate Professor of Medicine at Chobanian and Avedisian School of Medicine (BUSM) and a medical oncologist at Boston Medical Center (BMC) who has a lifelong passion for social justice. After college, Dr. Ko participated in Teach For America followed by volunteer service at the Berkeley Free Clinic in the Bay Area. She went on to Johns Hopkins School of Medicine and School of Public Health to complete her MD MPH with a focus on health outcomes research for vulnerable populations. After internal medicine residency at Brigham and Women's Hospital she arrived for fellowship in hematology/oncology at BUSM/BMC, which allowed Dr. Ko to conduct research in the context of caring for an underserved population within a large safety net institution. She has sought out meaningful projects that are a culmination of her passion for oncology, service to the underserved, and academic research. Her research has a translational focus that has been directed to understanding the disconnect between scientific discoveries in cancer treatment and delivery of evidence-based treatment to vulnerable, racial/ethnic minority women with breast cancer. She is actively investigating how tumor biology, poverty, communication and treatment influence breast cancer outcomes in diverse breast cancer populations.

Diversity, Equity, Inclusion and Accessibility

I am the child of Chinese immigrants. Growing up with parents who dedicated their lives to the enduring hope of the American dream for their children and grandchildren has shaped my values and guided my life choices. I seek to right the imbalance in our society with dedicated service for those who are vulnerable to structural racism, sexism and other inequalities inherent in our society. From my decision to be an American Studies major in college, to my participation in Teach for America and volunteer work at the Berkeley Free Clinic, I have consistently sought opportunities to understand, respect and serve communities in need.

It is a privilege and honor to treat patients and families who find Boston Medical Center (formerly Boston City Hospital) to be their medical home. As the largest safety net hospital in New England, I am grateful to practice alongside providers who strive for exceptional care without exception. My research is singularly focused on breast cancer disparities (see other tabs). In 2019 I participated in the BRIM (Bias Reduction in Medicine) training. Currently, I am on both the Section Anti-Racism Committee and Women in Oncology group.

Boston University
BU-BMC Cancer Center

Boston University
Center of Excellence in Women’s Health

Boston University
Evans Center for Interdisciplinary Biomedical Research

Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer – C
07/05/2019 - 05/31/2024 (PI)
Dana Farber Cancer Institute National Cancer Inst

Mechanisms of BET bromodomain metabolic reprogramming in tri
08/07/2018 - 07/31/2023 (PI)
Trustees of Boston University, BUMC National Cancer Inst

DFCI 17-101: Palbociclib After CDK and Endocrine Therapy (PACE): A Randomized Phase II Study…
01/02/2020 - 01/01/2023 (PI)
Dana Farber

Disparities in Breast Cancer Knowledge and Treatment Adheren
01/01/2020 - 12/31/2022 (PI)
Dana Farber Cancer Institute

Increasing Receipt of Guideline Concordant Survivorship Care Among Black Breast Cancer Survivors…
01/01/2020 - 12/31/2022 (PI)
Mass General Hosp Pfizer, Inc

Multiscale analysis of metabolic inflammation as a driver of
09/09/2020 - 08/31/2022 (PI)
Trustees of Boston University, BUMC National Cancer Inst

Improving Cancer Equity: Community-Based Engagement and Interventions
01/03/2018 - 02/28/2022 (PI)
Mass General Hosp Kraft Center for Com

Team-based Management of CDK 4/6 inhibitors
02/25/2020 - 12/31/2021 (PI)

Disparities in Breast Cancer Knowledge and Treatment Adherence
01/01/2019 - 12/31/2020 (PI)
Dana Farber American Cancer Soc


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Irwin KE, Ko N, Walsh EP, Decker V, Arrillaga-Romany I, Plotkin SR, Franas J, Gorton E, Moy B. Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care. Oncologist. 2022 Jul 05; 27(7):518-524. PMID: 35443045; PMCID: PMC9256021; DOI: 10.1093/oncolo/oyac069;
  2. Battaglia TA, Gunn CM, Bak SM, Flacks J, Nelson KP, Wang N, Ko NY, Morton SJ. Patient navigation to address sociolegal barriers for patients with cancer: A comparative-effectiveness study. Cancer. 2022 Jul 01; 128 Suppl 13:2623-2635.View Related Profiles. PMID: 35699610
  3. Huang HC, Smart MH, Zolekar A, Deng H, Hubbard CC, Hoskins KF, Ko NY, Guadamuz JS, Calip GS. Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity. Breast Cancer Res Treat. 2022 Jun; 193(3):707-716. PMID: 35460499
  4. Coleman C, Yan CH, Ko NY, Nabulsi NA, Hoskins KF, Chiu BC, Calip GS. Physical functioning, frailty and risks of locally-advanced breast cancer among older women. Breast. 2022 Aug; 64:19-28. PMID: 35468476; PMCID: PMC9039876; DOI: 10.1016/j.breast.2022.04.005;
  5. Calip GS, Nabulsi NA, Hubbard C, Asfaw AA, Lee I, Zhou J, Cueto J, Mitra D, Ko NY, Hoskins KF, Law EH. Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes Control. 2022 May; 33(5):793-799. PMID: 35226243; PMCID: PMC9010392; DOI: 10.1007/s10552-022-01561-2;
  6. Mukand NH, Ko NY, Nabulsi NA, Hubbard CC, Chiu BC, Hoskins KF, Calip GS. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Breast Cancer. 2022 Mar; 29(2):287-295. PMID: 34797467; PMCID: PMC8885772; DOI: 10.1007/s12282-021-01309-x;
  7. LeClair AM, Battaglia TA, Casanova NL, Haas JS, Freund KM, Moy B, Parsons SK, Ko NY, Ross J, Ohrenberger E, Mullikin KR, Lemon SC. Assessment of patient navigation programs for breast cancer patients across the city of Boston. Support Care Cancer. 2022 Mar; 30(3):2435-2443.View Related Profiles. PMID: 34767089; PMCID: PMC8962605; DOI: 10.1007/s00520-021-06675-y;
  8. Zhou J, Cueto J, Ko NY, Hoskins KF, Nabulsi NA, Asfaw AA, Hubbard CC, Mitra D, Calip GS, Law EH. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race. Breast. 2021 Oct; 59:367-375. PMID: 34419726; PMCID: PMC8379689; DOI: 10.1016/j.breast.2021.08.005;
  9. Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Res Treat. 2021 Oct; 189(3):769-779. PMID: 34241741
  10. Zhou J, Sweiss K, Han J, Ko NY, Patel PR, Chiu BC, Calip GS. Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410. PMID: 34313746; PMCID: PMC8316999; DOI: 10.1001/jamanetworkopen.2021.18410;
Showing 10 of 57 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 57 publications over 12 distinct years, with a maximum of 14 publications in 2020


2022 Arnold Gold Humanism in Medicine Award
2021 BUMG: Excellence in Care Award
2015 MIT Grand Hackathon: First Place
2012 MSCO: Merit Award
2012 ASCO: Merit Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Breast Cancer
Cancer Disparities
Health Services Delivery Research
Health Equity

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

FGH building, 1st floor, 820 Harrison Avenue
Boston MA 02118
Google Map

617.638.5756 (fax)

Ko's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department